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ABSTRACT
Objectives We evaluated the risk of lung cancer 
associated with ever working as a painter, duration 
of employment and type of painter by histological 
subtype as well as joint effects with smoking, within the 
SYNERGY project.
Methods Data were pooled from 16 participating 
case–control studies conducted internationally. Detailed 
individual occupational and smoking histories were 
available for 19 369 lung cancer cases (684 ever 
employed as painters) and 23 674 age- matched and 
sex- matched controls (532 painters). Multivariable 
unconditional logistic regression models were adjusted 
for age, sex, centre, cigarette pack- years, time- since- 
smoking cessation and lifetime work in other jobs that 
entailed exposure to lung carcinogens.
Results Ever having worked as a painter was associated 
with an increased risk of lung cancer in men (OR 1.30; 
95% CI 1.13 to 1.50). The association was strongest 
for construction and repair painters and the risk was 
elevated for all histological subtypes, although more 
evident for small cell and squamous cell lung cancer than 
for adenocarcinoma and large cell carcinoma. There was 
evidence of interaction on the additive scale between 
smoking and employment as a painter (relative excess 
risk due to interaction >0).
Conclusions Our results by type/industry of painter 
may aid future identification of causative agents or 
exposure scenarios to develop evidence- based practices 
for reducing harmful exposures in painters.
INTRODUCTION
Lung cancer is the most common cancer diagnosis 
worldwide and is the major cause of cancer mortality 
in men; an estimated 1 368 524 men and 725 352 
women were diagnosed with incident lung cancer in 
2018.1 Approximately 70% of the lung cancer burden 
can be attributed to smoking alone2 3; however ‘occu-
pational exposure as a painter’ has also been classified 
as an independent risk factor4 by the International 
Agency for Research on Cancer (IARC). Most of the 
published studies reported on ever employment as a 
painter; few studies have presented detailed analyses by 
type of painter, duration of employment, histological 
subtype of lung cancer or adjustment for exposure to 
Key messages
What is already known about this subject?
 ► ‘Occupational exposure as a painter’ has been 
classified as carcinogenic to humans by the 
International Agency for Research on Cancer, 
primarily due to an increased risk of lung 
cancer in epidemiological studies. Most of the 
published studies reported on ever employment 
as a painter; few presented detailed analyses 
by type of painter, duration of employment, 
histological subtype of lung cancer or 
adjustment for exposure to other occupational 
lung carcinogens.
What are the new findings?
 ► This pooled analysis of 19 369 cases (684 
painters) and 23 674 controls (532 painters) is 
the largest study to corroborate the increased 
risk of lung cancer in painters. The highest 
risks were observed for construction and repair 
painters and for the small cell, and squamous 
cell histological subtypes. The analyses 
accounted for detailed individual smoking 
habits and employment in other occupations 
with potential exposure to lung carcinogens.
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other occupational lung carcinogens. Painters are exposed to many 
known and suspected lung carcinogens, such as silica, asbestos, talc 
containing asbestos fibres, chromium VI compounds and cadmium 
compounds4 5; however, it is currently unclear to what extent these 
agents contribute to the increased lung cancer risk in painters and 
whether there are other factors that may contribute. Reporting data 
by type of painter may further elucidate the role of different poten-
tial causative agents and have important implications for work-
place policies and compensation of occupational cancer in painters. 
Therefore within the SYNERGY study, a large international pooled 
analysis of 16 case–control studies of lung cancer, we assessed asso-
ciations with employment as a painter, type of painter and duration 
of employment with adjustment for detailed smoking history and 
employment in other occupations with known or suspected lung 
cancer risk. We also assessed the joint effects of occupation as a 
painter and tobacco smoking in the risk of lung cancer, by histolog-
ical subtype when possible.
METHODS
This manuscript is formatted according to the STrengthening the 
Reporting of OBservational studies in Epidemiology (STROBE) 
statement for reporting case–control studies.6
Data for the SYNERGY project were pooled from 16 
population- based or hospital- based case- control studies of 
lung cancer from Europe, Canada, China and New Zealand 
conducted between 1985 and 2010; 15 of these studies 
collected lifetime tobacco smoking and occupational histo-
ries. The IARC multicentre INCO study was composed 
of seven study centres. The SYNERGY project has been 
described previously.7 Seven of the 16 studies previously 
published results on lung cancer in painters: AUT,8 HdA,9 10 
INCO,11 TURIN/VENETO and ROME,12 MONTREAL13 and 
HONG- KONG.14
Some noteworthy design features of the included studies: 
(1) most frequency- matched cases and controls on age and sex, 
conducted face to face interviews (84%), and asked about life-
time history of jobs held for more than 1 year15; (2) the Hong 
Kong, LUCAS and LUCA studies were restricted to men and 
the PARIS study included only regular smokers; (3) all studies, 
except MORGEN, provided data on lifetime smoking habits 
and complete self- reported occupational history until diagnosis 
or recruitment. MORGEN is a case–control study nested in the 
European Prospective Investigation into Cancer and Nutrition 
study in the Netherlands, where 45% of those invited completed 
a questionnaire at recruitment; (4) the occupational data were 
coded or recoded from national classifications into the Inter-
national Standard Classification of Occupations (ISCO-68).16 
Ethical consent was obtained in accordance with the legisla-
tion in each country and also by the IARC Ethics Committee. 
The SYNERGY project is coordinated by IARC, the Institute 
for Prevention and Occupational Medicine of the German 
Social Accident Insurance, and the Institute for Risk Assessment 
Sciences at Utrecht University. More information is available at 
http:// synergy. iarc. fr.
Exposure assessment
Painters were categorised by job and industry codes into painting 
industry/‘type of painter’' by two industrial hygienists (HK, RV). 
The categories of painting industry are comprised of combina-
tions of 5- digit ISCO and 4- digit ISIC codes (ISCO 9–3 X.XX), 
as described in online supplemental table 1, to categorise by 
chemical composition of paint and type of application. ‘Spray 
painters’ were a subset of manufacture painters believed a priori 
to have a different exposure profile than manufacture painters.
Duration of employment was determined using the total 
number of years employed as a painter in the persons’ working 
life. ‘Ever painter’ was defined as minimum 1 year of employ-
ment. Seventeen painters (6 cases, 11 controls) that had missing 
data on start and/or end date of employment were omitted from 
the analyses of duration (data not shown).
Statistical analysis
To investigate the association between occupational exposure as a 
painter and lung cancer risk, ORs and 95% CIs were computed 
using unconditional logistic regression models. Two exposure 
metrics were considered: ever vs never being employed as a painter, 
and the duration of employment as painters (years). Duration of 
employment was categorised into tertiles (1–5, 6–17, >17 years) 
based on the duration distribution among control subjects that had 
worked as painters. Subjects who were never employed as painters 
were considered as the reference category in analysis for both expo-
sure metrics. Models were adjusted for study (individual centres of 
the IARC study in Central and Eastern Europe and the UK (INCO) 
were treated as separate studies), age, cigarette pack- years (cPY), 
time- since- quitting smoking cigarettes (categorised as current 
smokers; quitting 2–7, 8–15, 16–25, 26–35, 36+ years before diag-
nosis/interview and never- smokers), ever- employment (yes/no) in 
an industry or occupation with known (list A) or suspected (list B) 
association with the risk of lung cancer.17 18 Painters were excluded 
from list A for this analysis (online supplemental table 2). Current 
smokers were defined in most studies as having smoked at least one 
cigarette per day for 6 months or more, and also included those 
who had stopped smoking in the last 2 years before diagnosis or 
interview, as recent smoking cessation could be due to early symp-
toms of the disease. The cPY was calculated as follows: Σ duration 
(years) X average cigarette smoked per day/20 (cigarettes per pack) 
and was included as log(1+cPY) in the logistic regression models in 
order to approximate log- normal distribution.
Analyses were performed both overall and separately by sex to 
account for potential sex differences in job tasks and subsequent 
exposures. Stratified analyses were also performed by type of 
painter and by lung cancer subtype. Linear trends in ORs across 
categories of duration of employment as painters, starting from 
never being a painter, were examined by treating categories as 
equally spaced ordinal variables in the logistic regression models. 
In female painters, the analyses by duration of employment, and 
by histological subtype, were dropped because there were too 
few exposed cases.
Interactions on a multiplicative scale were assessed using an 
interaction term between occupation as a painter (never vs ever 
painter) and smoking status (never vs ever smoker) in logistic 
regression models.
Key messages
How might this impact on policy or clinical practice in the 
foreseeable future?
 ► As several million people are employed as painters 
worldwide, even a modest increase in lung cancer risk 
is notable for prevention efforts to reduce the burden of 
occupational lung cancer. Our results by type/industry of 
painter may aid future identification of causative agents or 
exposure scenarios to develop evidence- based practices for 
reducing harmful exposures in painters.
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Interactions on an additive scale were assessed by fitting linear 
OR models and calculating the relative excess risk due to inter-
action (RERI), in order to test the departure from additivity of 
the effects of both risk factors (painter and smoking status).19 
Linear OR models were adjusted for study, age, and list A and 
B, and performed both overall and by sex. RERI estimates along 
with 95% CIs based on the delta method are reported.20 21 Never 
smokers and never painters were considered as the reference 
category. RERI- based analyses in women are not presented due 
to the sparse number of female painters who never smoked in 
certain sub- categories. The RERI measures the extent to which 
the effect of both exposures combined exceeds the sum of the 
effects of each considered separately and is thus given by OR11 - 
OR10 - OR01 +1, where ORij is the OR for lung cancer comparing 
the group with exposures i and j to the reference category. A 
RERI>0 indicates a positive additive interaction where the 
effect of both exposures together exceeds the sum of the two 
exposures considered separately. We also reported the attribut-
able proportion (AP) of cancer risk that is due to the additive 
interaction between the two exposures (range −100 to 100%), 
which is defined by the ratio of the RERI to the risk among the 
doubly exposed group, OR11, (RERI/ OR11).
Random effects meta- analyses, using the adjusted ORs by 
centre, was conducted using the STATA ‘metan’ command 
(online supplemental figure 1) in order to (1) compute summary 
estimates and 95% CIs comparing ‘ever’ with ‘never’ being a 
painter across studies and (2) to explore heterogeneity between 
studies, expressed as a percentage (I2). The I2 statistic quanti-
fies the amount of inconsistency between studies22 and estimates 
the percentage of total variation across studies that is due to 
heterogeneity rather than chance. I2 ranges from 0% and 100%; 
a value of 0% indicates no observed heterogeneity, and larger 
values show increasing heterogeneity. There will be differences 
in the summary estimates produced from the pooled and meta- 
analysis due to differences in weighting.23
Various sensitivity analyses were conducted to investigate 
factors contributing to heterogeneity in the summary estimate 
(online supplemental table 3). The robustness of the overall risk 
estimate was also assessed by dropping individual studies one at 
a time. Analyses were performed using SAS V.9.3, Stata (V.11.0) 
and R statistical software (V.3.4.1). P values are two sided.
RESULTS
Table 1 describes selected characteristics of participants in the 
SYNERGY pooled analysis by ever- painter status. Roughly 5% 
of ever- painters were women, while the corresponding propor-
tion among never- painters was around 20%. Ever- painters were 
slightly younger than never- painters, more often current smokers 
and less often never smokers.
Table 2 describes the 16 studies included in the SYNERGY 
pooled analysis, comprising 19 369 cases (684 painters) and 
23 674 controls (532 painters). Case and control participation 
ranged from 53% to 98% and 41% to 100%, respectively.
The meta- analysis and additional sensitivity analyses show 
no to low/moderate heterogeneity (I2 <50%) by various 
strata (ie, control source, region, sample size and the end year 
of data collection) (online supplemental table 3 and figure 1). 
Omitting studies one at a time had no effect on the overall 
meta- OR (meta- OR, 1.26; 95% CI 1.09 to 1.44; I2=0); the 
meta- OR changed slightly but remained elevated when drop-
ping the three studies with the largest weights (AUT, ICARE, 
EAGLE) (meta- OR, 1.19; 95% CI 0.99, 1.43; I2=0) but did 
not change significantly when restricting to studies with 
control participation >50% (OR, 1.23; 95% CI 1.06 to 1.44; 
I2=0%; 19 studies) and >75% (OR, 1.24; 95% CI 0.99 to 
1.55; I2=18.7%; 14 studies).
Painters experienced an increased risk of lung cancer (table 3). 
Men who were ever employed as a painter (for at least 1 year) 
had an OR for lung cancer of 1.30 (95% CI 1.13 to 1.50; 649 
exposed cases). Painters were also categorised by industry/painter 
type according to ISCO and ISIC codes (online supplemental 
table 1). The highest risk was observed for construction painters 
(OR in men=1.31; 95% CI 1.11 to 1.55) and repair painters 
(OR in men=1.38; 95% CI 0.87 to 2.20). Similar patterns were 
observed for women—although on much smaller numbers—and 
also in the analyses of men and women combined. A trend with 
duration of employment was observed for construction painters 
(p≤0.001).
Table 4 shows that the results were comparable across histo-
logical subtypes. Generally, the magnitude of lung cancer risk 
was highest in the highest category of duration of employ-
ment; however, the test for trend was significant only among 
all subjects (p values for trend <0.05) but not when excluding 
never painters (p values for trend >0.05). Similar patterns were 
observed in the analyses for men and women combined. When 
analyses were restricted to women only, numbers were too small 
for any meaningful analyses by histological subtype.
Joint effects of smoking status and ever/never employment as 
a painter are presented overall and by lung cancer subtype, sepa-
rately by sex and also for men and women combined in table 5. 
Among never smokers who had ever worked as a painter, there 
was a twofold increased risk of lung cancer for all subtypes (OR 
2.04; 95% CI 1.18 to 3.53) and was highest for the adenocar-
cinoma subtype (OR 2.63; 95% CI 1.33 to 5.18). Results for 
other histological subtypes were not informative due to the 
small number of painters who never smoked (n<5). Compared 
with the reference category of those who had never smoked nor 
worked as a painter, the highest risk of lung cancer was observed 
among smokers who had ever worked as a painter (overall OR 
in men=16.48; 95% CI 14.05 to 19.33). There was evidence 
of interaction on the additive scale (RERI>0) for lung cancer 
in men (RERI 3.93; 95% CI 1.55 to 6.30); nearly a fourth of 
the lung cancers among those who had ever worked as a painter 
and also ever smoked could be attributed to the interaction (AP 
23.85; 95% CI 12.07 to 35.62). While similar patterns were 
observed in analyses for men and women combined, there was 
no evidence of additive interaction for women (data not shown).
DISCUSSION
This is the largest study to date to assess the association between 
occupation as a painter and risk of lung cancer, by type of 
painting activity as well as histological subtype, while accounting 
for lifetime smoking habits and other occupations with poten-
tial exposure to occupational lung carcinogens. Our results are 
in line with several publications that reported increased rela-
tive risks for lung cancer among painters after adjustment for 
smoking.4 Ever having worked as a painter was associated with 
an increased risk of lung cancer of similar magnitude in this 
pooled analysis (OR 1.29; 95% CI 1.12 to 1.48) and in a meta- 
analysis (RR 1.35; 95% CI 1.21 to 1.51)24 which included 4 
of the 16 studies from the present pooled analysis.8 9 12 25 The 
SYNERGY pooled analysis had additional advantages over the 
meta- analysis in that there was harmonised and refined expo-
sure assessment and adjustment for potential confounders using 
the raw data. The association was strongest for construction 
and repair painters and the risk was elevated for all histological 
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subtypes, although more expressed for small cell and squamous 
cell lung cancer than for adenocarcinoma and large cell carci-
noma. We believe our results are generalisable to other popula-
tions not studied in this pooling project as the data come from 
16 studies conducted in globally diverse populations from China, 
New Zealand, Canada and across Europe.
There was evidence of interaction on an additive scale between 
smoking and employment as a painter (RERI >0), suggesting 
that public health consequences of an intervention on occupa-
tional exposure as a painter would have greater benefit among 
ever smokers than among never smokers. It is noteworthy that 
an increased risk of lung cancer was also observed in never 
smokers who had worked as painters, relative to those who were 
never smokers and never painters.
Complete individual job histories in the form of job titles were 
available in SYNERGY. Although job titles were self reported, 
there is no reason to suspect that cases would over report 
employment as a painter compared with controls. Therefore, 
any potential exposure misclassification would likely be non- 
differential and bias the risk estimates towards the null. Further-
more, occupation as a painter is a clear cut job title, which 
reduces the potential for exposure misclassification.
Not all painters have the same exposures, not even within 
subcategories, and this is even more an issue when the lung 
cancer excess may be the result of a mix of various carcinogenic 
exposures. Several factors will determine exposures in painters. 
For example, construction painters most often use rollers and 
brushes, rather than spray- guns, which result in relatively low 
Table 1 Selected characteristics of study participants in the SYNERGYy analysis of painters
Study participants’ characteristics










  Men 649 94.9 504 94.7 14 959 80.1 18 027 77.9
  Women 35 5.1 28 5.3 3 726 19.9 5 115 22.1
Age, years
  <45 45 6.6 29 5.5 758 4.1 1 456 6.3
  45–49 52 7.6 38 7.1 1 115 6 1 413 6.1
  50–54 99 14.5 68 12.8 1 915 10.3 2 254 9.7
  55–59 125 18.3 77 14.5 2 833 15.2 3 388 14.6
  60–64 131 19.1 96 18.1 3 485 18.6 4 051 17.5
  65–69 103 15.1 108 20.3 3 892 20.8 4 818 20.8
  70–74 100 14.6 86 16.2 3 319 17.8 4 371 18.9
  75+ 29 4.2 30 5.6 1 368 7.3 1 391 6
Histological subtype
  SqC 279 40.8 – – 6904 36.9 – –
  SCLC 110 16.1 – – 2913 15.6 – –
  AC 176 25.7 – – 5462 29.2 – –
  LCC 30 4.4 – – 836 4.5 – –
  Others* 89 13 – – 2570 13.8 – –
Ever employed in a list A/B job†
  No 445 65.1 342 64.3 12 959 69.4 17 819 77
  List A 53 7.7 42 7.9 1 040 5.6 810 3.5
  List B 156 22.8 133 25 4 134 22.1 4 107 17.7
  List A and List B 30 4.4 15 2.8 552 2.9 406 1.8
Smoking status
  Never smokers 25 3.7 99 18.6 1 429 7.6 7 681 33.2
  Former smokers 160 23.4 232 43.6 5 840 31.3 9 021 39
  Current smokers 497 72.7 199 37.4 11 377 60.9 6 371 27.5
  Unknown/missing 2 0.3 2 0.4 39 0.2 69 0.3
Pack- years cigarette smoking, ever smoker: AM (SD) 42.53 (25.6) 28.56 (24.0) 42.42 (27.9) 26.25 (23.8)
Time since quitting smoking, former smokers: AM (SD) 12.05 (9.2) 18.01 (11.7) 12.99 (10.3) 20.10 (12.1)
Time since quitting smoking, years
  2–7 58 8.5 39 7.3 1 850 9.9 1 341 5.8
  8–15 39 5.7 61 11.5 1 649 8.8 2 002 8.7
  16–25 36 5.3 58 10.9 1 207 6.5 2 468 10.7
  26–35 13 1.9 42 7.9 466 2.5 1 623 7
  >35 2 0.3 16 3 216 1.2 1 062 4.6
  Missing 14 2 18 3.4 491 2.6 594 2.6
  Never smoker 25 3.7 99 18.6 1 429 7.6 7 681 33.2
*Others include others, unspecified and missing values.
†Occupation with known (list A) or suspected (list B) association with the risk of lung cancer.
AC, adenocarcinoma; AM, arithmetic mean; LCC, large cell carcinoma; SCLC, small cell lung cancer; SqC, squamous cell carcinoma.
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exposure to solvents and paint. However, the work needed to 
prepare a surface before painting can involve high exposure to 
dust from paint and may result in exposures like asbestos, lead 
and silica.26
Repair painters are generally exposed for shorter times. The 
actual paint spraying takes place for a limited period of time 
in body shops since repair painters must perform several other 
tasks before the painting can take place.27
Spray painters in SYNERGY had an increased risk of lung 
cancer, consistent with previously published studies.14 Spray 
painters may experience exposure to higher solvent concentra-
tions and are exposed to aerosolised compounds which may be 
hazardous to the lung.28 Spray painters in truck and aeroplane 
manufacturing may have had exposure to hexavalent chromium 
used as a pigment to prevent rusting. Although spray painters 
often use personal protective equipment (eg, coveralls and respi-
ratory protection), this may not have been true for earlier time 
periods of exposure.
There was, however, low precision for some of the analyses by 
type of painter, which was mostly due to small numbers in some 
strata. These limitations create challenges to identifying specific 
causative agents. Nevertheless, our analyses by type of painter 
and the characterisation of exposures by work environments in 
online supplemental table 1 can inform future studies to iden-
tify the agents responsible for the increased lung cancer risk in 
different subsets of painters. Future epidemiological studies that 
specifically assess exposure to these compounds among painters 
are needed to identify to what extent the known carcinogens 
contribute to the increased lung cancer risk and whether other 
causative agents play an additional role.
The higher OR 1.35 (95% CI 1.05 to 1.74) observed for 
studies conducted before 1995 compared with after 1995 (OR 
1.19; 95% CI 1.00 to 1.42) (online supplemental table 3) may 
illustrate changes to the composition of paints over time29 that 
were undertaken in response to directives to reduce emissions of 
volatile organic compounds from 1999 onwards.30
The observed associations were lower in the hospital- based 
case- control studies; most enrolled only patients with diseases 
that were not related to smoking and were careful in including 
several diagnostic groups with a varied referral pattern.31 The 
hospital- based studies were also generally smaller in size, so it is 
possible that they were underpowered to detect a potential risk 
in painters in the individual studies. Although participation in 
the studies using population- based controls was generally lower 
than in studies using hospital- based controls, only a few studies 
included in the pooled analysis had <50% participation among 
population controls. Low participation can endanger represen-
tativeness and therefore provide opportunity for bias; however, 
low response does not result in selection bias any more than 
high response guarantees unbiased estimates.32 Although there is 
a potential for non- response bias due to the low level of subject 
participation, a low response rate in itself is not necessarily an 
indicator for the presence of non- response bias.33 34 Further-
more, the overall meta- OR (OR, 1.26; 95% CI 1.09 to 1.44; 
I2=0; 22 studies) was neither affected by omitting studies one at 
a time nor restricting to studies with control participation >50% 
(OR, 1.23; 95% CI 1.06 to 1.44; I2=0%; 19 studies) or >75% 
(OR, 1.24; 95% CI 0.99 to 1.55; I2=18.7%; 14 studies).
We consider the impact of potential recall bias has been at 
most moderate in SYNERGY because there was no emphasis 
placed on any particular occupation. It is generally accepted that 
for jobs held longer, the validity and reliability of self- reported 
job history obtained with an interviewer- administered ques-
tionnaire is not an important source of recall bias.18 35 36 More 























AUT Germany 1990–1995 1932–1994 P 3 180 77 3.1 3 249 41 2
CAPUA Spain 2000–2010 1941–2004 H 875 91 3.4 838 96 3
EAGLE Italy 2002–2005 1942–2005 P 1 943 87 3.9 2 116 72 2.2
HdA* Germany 1988–1993 1926–1993 P 1 004 69 4.7 1 004 68 2.8
HONG- KONG* China 2003–2007 1940–2007 P 1 207 96 2.7 1 069 48 0.8
ICARE France 2001–2007 1944–2007 P 2 926 63 5 3555 77 2.5
INCO_ Cz. Rep* Czech Republic 1998–2002 1941–2001 H 304 94 2.3 453 80 0.6
INCO_Hungary* Hungary 1998–2001 1952–1999 H 402 90 2.7 315 100 2.2
INCO_Poland* Poland 1999–2002 1946–2000 H+P 800 88 3.3 841 88 2
INCO_Romania* Romania 1998–2001 1955–2000 H 181 90 3.9 228 99 2.6
INCO_Russia* Russia 1998–2000 1949–2000 H 600 96 1.8 580 90 3.6
INCO_Slovakia* Slovakia 1998–2002 1942–2002 H 346 90 2 285 84 1.4
INCO_UK* UK 1998–2005 1934–2002 P 442 78 5.7 918 84 4
LUCA France 1989–1992 1938–1991 H 309 98 4.5 302 98 2.3
LUCAS Sweden 1985–1990 1927–1990 P 1 042 87 2 2 356 85 2.2
MONTREAL* Canada 1996–2002 1935–1999 P 1 203 85 2.2 1 509 69 1.5
MORGEN The Netherlands 1993–1997 1953–1993 P 71 N/A 1.4 202 N/A 1.5
OCANZ New Zealand 2003–2008 1954–2008 P 457 53 2.2 792 48 2
PARIS France 1988–1992 1942–1991 H 173 95 2.3 234 95 4.3
ROME Italy 1993–1996 1933–1995 H 347 74 3.5 365 63 3
TURIN/VENETO* Italy 1990–1994 1928–1993 P 1 132 79 5.9 1 553 80 3
TORONTO Canada 1996–2003 1949–2000 H+P 425 62 1.2 910 71 0.9
*These studies have previously published their results on painters: AUT (Bruske- Hohlfeld et al 2000),8 HdA (Jöckel et al10; Jahn et al),9 INCO (Zeka et al),25 MONTREAL (Ramanakumar et al)13; 
TURIN/VENETO (Richiardi et al)12; HONG- KONG (Tse et al). These published studies, except for Ramanakumar et al13 and Tse et al,14 were included in a meta- analysis that assessed lung cancer risk 
in painters (Guha et al24, published online 2009)
H, hospital based; P, population based. copyright.
 on M
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than one- third of the painters in our study were employed long 
term, minimising the impact of potential information bias (40% 
employed as a painter for >17 years, the highest employment 
duration category (range 1–57 years).
Recall bias can affect the measurement of confounders, 
resulting in reduced ability to control for confounding. Smoking 
data were collected through self- report and there was potential 
for misclassification. The ORs in men were higher for squa-
mous cell and small cell carcinomas, the histological subtypes of 
lung cancer most strongly associated with smoking.37 Residual 
confounding by tobacco smoking was possible, although less 
likely than in many other case- control studies due to the high 
quality of smoking data, as reflected by the very high ORs 
for smoking and lung cancer.37 The adjustment for smoking, 
modelled by cumulative exposure (log cPY) and time since quit-
ting may have been imperfect. Adjusting for cigarette smoking 
alone likely had a negligible impact on the results since few 
study participants smoked other types of tobacco. The number 
of cases among painters who never smoked were too few in the 
analyses of squamous cell and small cell carcinomas, precluding 
further interpretation. However, it is noteworthy that painters 
who never smoked experienced a statistically significant 
increased risk of lung cancer, for all histologies combined and 
for adenocarcinomas.
In summary, we observed an association between employ-
ment as painter and risk of lung cancer in our large international 
pooled study, which is in agreement with the IARC classification 
of ‘occupational exposure as a painter’ as being carcinogenic to 
humans. These results were robust to accounting for smoking 
behaviour as well as coemployment in industries or occupa-
tions with known or suspected lung cancer risk and are further 
supported by positive exposure- response trends. Our findings by 
type of painter may aid the identification of agents or exposure 
scenarios that contribute to the increased risk, which is neces-
sary to develop evidence- based practices for reducing harmful 
workplace exposures. As several million people are employed as 
painters worldwide,38 even a modest increase in lung cancer risk 
is notable for prevention efforts targeted to reducing harmful 
exposures.
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Table 4 Risk of lung cancer in painters, stratified by histological subtype
Work as painter
SqC SCLC AC LCC
Cases 
n=6414 OR (95% CI)*
Cases 
n=2426 OR (95% CI)*
Cases 
n=4014 OR (95% CI)*
Cases 
n=667 OR (95% CI)*
Men
  Never 6 139 1 2 322 1 3 854 1 637 1
  Ever 275 1.38 (1.16 to 1.64) 104 1.4 (1.09 to 1.78) 160 1.23 (1.00 to 1.51) 30 1.22 (0.80 to 1.86)
  Duration employment (years)
   1–5 83 1.28 (0.93 to 1.72) 29 1.2 (0.77 to 1.87) 45 1.02 (0.70 to 1.48) 14 1.53 (0.81 to 2.91)
   6–17 79 1.52 (1.09 to 2.12) 27 1.52 (0.95 to 2.42) 40 1.29 (0.86 to 1.94) 6 0.99 (0.39 to 2.51)
   >17 109 1.46 (1.11 to 1.92) 48 1.61 (1.12 to 2.31) 75 1.48 (1.09 to 2.03) 10 1.17 (0.58 to 2.37)
  Test for trend, p value
Men and Women
  Never 6 904 1 2 913 1 5 462 1 836 1
  Ever 279 1.35 (1.14 to 1.61) 110 1.39 (1.09 to 1.76) 176 1.23 (1.01 to 1.51) 30 1.18 (0.77 to 1.80)
  Duration employment (years)
   1–5 89 1.24 (0.92 to 1.67) 32 1.21 (0.79 to 1.86) 54 1.05 (0.74 to 1.49) 14 1.48 (0.78 to 2.82)
   6–17 80 1.48 (1.07 to 2.04) 28 1.46 (0.92 to 2.31) 44 1.26 (0.85 to 1.87) 6 0.97 (0.38 to 2.45)
   >17 109 1.47 (1.12 to 1.93) 50 1.65 (1.15 to 2.37) 78 1.53 (1.12 to 2.08) 10 1.17 (0.58 to 2.37)
  Test for trend, p value <0.001 0.001 0.004 0.50
*Adjusted for study, age, pack- years, time since quitting smoking, occupational exposures (list A and B jobs), sex (only for analysis of men and women combined).
AC, adenocarcinoma; LCC, large cell carcinoma; SCLC, small cell lung cancer; SqC, squamous cell carcinoma.
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